RPT-PREVIEW-Safety is key for upcoming Isis cholesterol data
LOS ANGELES, Aug 1 (Reuters) - Isis Pharmaceuticals Inc will soon release key data from pivotal trials of its experimental cholesterol drug that will be closely parsed for evidence of any safety risks, particularly liver toxicity.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here